Skip to main content

Table 2 TCGA Datasets Evaluated

From: Pan-cancer adaptive immune resistance as defined by the Tumor Inflammation Signature (TIS): results from The Cancer Genome Atlas (TCGA)

Symbol

N

Name

ACC

79

Adrenocortical carcinoma

BLCA

396

Bladder urothelial carcinoma

BRCA

1092

Breast invasive carcinoma

CESC

301

Cervical squamous cell carcinoma and endocervical adenocarcinoma

CHOL

36

Cholangiocarcinoma

COAD

280

Colon adenocarcinoma

DLBC

47

Lymphoid neoplasm diffuse large B-cell lymphoma

ESCA

183

Esophageal carcinoma

GBM

167

Glioblastoma multiforme

HNSC

516

Head and neck squamous cell carcinoma

KICH

65

Kidney chromophobe

KIRC

530

Kidney renal clear cell carcinoma

KIRP

270

Kidney renal papillary cell carcinoma

LAML

163

Acute myeloid leukemia

LGG

506

Brain lower grade glioma

LIHC

361

Liver hepatocellular carcinoma

LUAD

497

Lung adenocarcinoma

LUSC

483

Lung squamous cell carcinoma

MESO

87

Mesothelioma

OV

264

Ovarian serous cystadenocarcinoma

PAAD

179

Pancreatic adenocarcinoma

PCPG

184

Pheochromocytoma and paraganglioma

PRAD

493

Prostate adenocarcinoma

READ

95

Rectum adenocarcinoma

SARC

249

Sarcoma

SKCM

463

Skin cutaneous melanoma

STAD

409

Stomach adenocarcinoma

TGCT

139

Testicular germ cell tumors

THCA

504

Thyroid carcinoma

THYM

118

Thymoma

UCS

57

Uterine carcinosarcoma

UVM

80

Uveal melanoma